David Thurston

David Thurston

Company: Femtogenix

Job title: Chief Scientific Officer

Seminars:

New Developments with the Pyridinobenzodiazepine (PDD) ADC Payload Platform 5:00 pm

• Updates will be presented on the PDD platform, including high potency and low potency alkylators • A new high potency G-alkylator will be disclosed that exhibits a profile suitable for use in ADCs targeting solid tumours • Examples of efficacy and toxicity data for ADCs carrying the low-potency PDD G-monoalkylating payload FGX20-75 will be…Read more

day: Day One

Live Discussion & Question Time 5:20 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.